DE68906572D1 - Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. - Google Patents

Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
DE68906572D1
DE68906572D1 DE8989104008T DE68906572T DE68906572D1 DE 68906572 D1 DE68906572 D1 DE 68906572D1 DE 8989104008 T DE8989104008 T DE 8989104008T DE 68906572 T DE68906572 T DE 68906572T DE 68906572 D1 DE68906572 D1 DE 68906572D1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
compositions containing
inhibitoric
peptides
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989104008T
Other languages
English (en)
Other versions
DE68906572T2 (de
Inventor
Dario Chiarino
Angelo Carenzi
Bella Davide Della
Franco Pellacini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SpA filed Critical Zambon SpA
Publication of DE68906572D1 publication Critical patent/DE68906572D1/de
Application granted granted Critical
Publication of DE68906572T2 publication Critical patent/DE68906572T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
DE8989104008T 1988-03-16 1989-03-07 Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. Expired - Fee Related DE68906572T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8819791A IT1216104B (it) 1988-03-16 1988-03-16 Peptidi ad attivita' farmaceutica.

Publications (2)

Publication Number Publication Date
DE68906572D1 true DE68906572D1 (de) 1993-06-24
DE68906572T2 DE68906572T2 (de) 1993-08-26

Family

ID=11161247

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989104008T Expired - Fee Related DE68906572T2 (de) 1988-03-16 1989-03-07 Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Country Status (12)

Country Link
US (1) US5145872A (de)
EP (1) EP0333000B1 (de)
JP (1) JPH024748A (de)
AT (1) ATE89549T1 (de)
AU (1) AU611540B2 (de)
CA (1) CA1331419C (de)
DE (1) DE68906572T2 (de)
ES (1) ES2054904T3 (de)
IE (1) IE890748L (de)
IL (1) IL89538A0 (de)
IT (1) IT1216104B (de)
ZA (1) ZA891783B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0715008B2 (ja) * 1989-07-04 1995-02-22 帝人株式会社 圧縮成形用組成物
ES2052454B1 (es) * 1992-12-31 1995-01-16 Zambon S A Dipeptidos y composiciones que los contienen con accion farmaceutica contra el envejecimiento.
EP0679153A4 (de) * 1993-01-14 1996-05-15 Magainin Pharma Endständig modifizierte aminosäuren und peptide.
US5654451B1 (en) * 1993-01-14 2000-02-22 Magainin Pharma Amino acids and peptides having modified c-terminals and modified n-terminals
US5455262A (en) * 1993-10-06 1995-10-03 Florida State University Mercaptosulfide metalloproteinase inhibitors
FR2770844A1 (fr) * 1997-11-10 1999-05-14 Inst Nat Sante Rech Med Inhibiteurs de toxines clostridiales et compositions pharmaceutiques les contenant
WO2001036404A1 (en) * 1999-11-19 2001-05-25 Smithkline Beecham Corporation Compounds and methods
DE102006042147A1 (de) * 2006-09-06 2008-03-27 Dynamit Nobel Gmbh Explosivstoff- Und Systemtechnik Hydrochloride von 3-Amino-2-hydroxycarbonsäureamiden

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029547A (en) * 1974-07-01 1977-06-14 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Biologically active substance, bestatin, and production thereof
US4052449A (en) * 1974-07-01 1977-10-04 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Biologically active substance, bestatin, and production thereof
AR227636A1 (es) * 1978-11-25 1982-11-30 Nippon Kayaku Kk Procedimiento para producir acido treo-3-amino-2-hidroxibutanoil aminoacetico intermediarios para prepararlo y procedimiento para preparar los intermediarios
JPS5828867B2 (ja) * 1979-07-13 1983-06-18 財団法人 微生物化学研埋会 新テトラペプチド誘導体類
JPS5767516A (en) * 1980-09-24 1982-04-24 Microbial Chem Res Found Novel analgesic agent
US4933179A (en) * 1983-08-22 1990-06-12 Syntex (U.S.A.) Inc. Feline leukemia virus antigen vaccines
US4599325A (en) * 1984-02-16 1986-07-08 G. D. Searle & Co. Substituted tyrosyl alanine dipeptide amides
DE3628650A1 (de) * 1986-03-12 1987-09-24 Bayer Ag Renininhibitoren, verfahren zur herstellung und ihre verwendung
US4942154A (en) * 1987-06-18 1990-07-17 Merck & Co., Inc. Steroidal glycolipids as host resistance stimulators against viral infection
US4894392A (en) * 1987-08-27 1990-01-16 Merck & Co., Inc. Aminoalkyl naphthalenediols as host resistance enhancers
US4883808A (en) * 1987-08-27 1989-11-28 American Biotechnology Company Condensation products of cyclic diketones and ascorbic acid as immunomodulatory agents
US4900547A (en) * 1987-10-23 1990-02-13 University Of British Columbia Method to immunize mammals against tumors
IT1216103B (it) * 1988-03-16 1990-02-22 Zambon Spa Peptidi ad attivita' farmaceutica.

Also Published As

Publication number Publication date
EP0333000B1 (de) 1993-05-19
AU611540B2 (en) 1991-06-13
ZA891783B (en) 1989-11-29
IL89538A0 (en) 1989-09-10
IE890748L (en) 1989-09-16
IT1216104B (it) 1990-02-22
ES2054904T3 (es) 1994-08-16
US5145872A (en) 1992-09-08
JPH024748A (ja) 1990-01-09
AU3138389A (en) 1989-09-21
CA1331419C (en) 1994-08-09
IT8819791A0 (it) 1988-03-16
EP0333000A2 (de) 1989-09-20
EP0333000A3 (en) 1990-11-28
ATE89549T1 (de) 1993-06-15
DE68906572T2 (de) 1993-08-26

Similar Documents

Publication Publication Date Title
DE69030206T2 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung
ATE98651T1 (de) Peptide mit tachykininantagonistischer aktivitaet, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
ATE175201T1 (de) Mono-n-substituierte 1,4,7,10- tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DK0539204T3 (da) Antivirale 4-substituerede-deoxy-2,3-didehydroderivater af alfa-D-neuraminsyre
DE69627035T2 (de) Derivate von aminosäuren, sie enthaltende pharmazeutische zusammensetzungen sowie deren herstellunsgverfahren
DE69130412D1 (de) Pyrazolopyridinverbindung und Verfahren zu ihrer Herstellung
ATE104279T1 (de) 4-fluorbenzolderivate, herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen.
IT1224405B (it) Composti attivi sul sistema cardiovascolare
DE68906572D1 (de) Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE68909451D1 (de) Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69402004D1 (de) Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen
ATE144510T1 (de) N-(isochinolein-5-yl)-sulfonyl azazykloalkane, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
EA199700302A1 (ru) Биологически активные уреидо-производные, полезные при лечении рассеянного склероза
IT1273455B (it) Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
ATE279434T1 (de) Neue (3,4,7,8,9,10) hexahydro-6, 10-dioxo-6h- pyridazino /1, 2-a/ /1, 2/ diazepin-1-carbonsäure-derivate, verfahren zu deren herstellung und deren verwendung zur herstellung pharmazeutischer wirkstoffe
DK468482A (da) N-nitroso-n-(beta-chlorethyl)-carbamoyl-peptider
IT1224404B (it) Composti attivi sul sistema cardiovascolare
TH14322EX (th) สารประกอบไทรไซคลิคที่ต่อต้านฤทธิ์ของแทคิควินีน, การเตรียมและสูตรผสมทางเภสัชกรรมที่ประกอบด้วย สารประกอบนั้น
TH14322A (de)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee